டெட்ரா உயிர் பார்மா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Tetra Bio-Pharma Files PCT Patent Application for Cannabis Plant Residue
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Lobby Wrap: Group seeking funding for Northern 5G line
ipolitics.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipolitics.ca Daily Mail and Mail on Sunday newspapers.
Synthetic Cannabinoids Market to Grow at a CAGR of 16% Through 2029 – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Lobby Wrap: Ottawa asked to boost support for long-term care
ipolitics.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ipolitics.ca Daily Mail and Mail on Sunday newspapers.
Tetra Bio-Pharma: Health Canada Accepts New Drug Submission for REDUVO as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
The Company approaches a significant milestone advancing from a pre-revenue biotech to in revenue
OTTAWA, ON / ACCESSWIRE / June 2, 2021 /
Tetra Bio-Pharma
Inc. ( Tetra or the Company ) (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announced today that Health Canada has accepted its New Drug Submission (NDS) for REDUVO and has formally entered the final review phase in the drug review process. If successful, REDUVO will be issued a Notice of Compliance (NOC) as well as a Drug Identification Number (DIN) which permits Tetra to market the drug in Canada and indicates the drug s official approval in Canada.